ArticleBMJ health & care informatics2026
Predicting zero-dose vaccination status in 27 sub-Saharan African countries: a machine learning approach.
Article in BMJ health & care informatics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo develop a machine learning (ML)-based predictive model for assessing the risk of zero-dose children using Demographic Health Survey data in sub-Saharan Africa.
methodsThis study analysed pooled Demographic and Health Survey data from 27 countries in sub-Saharan Africa collected between 2016 and 2024. Data preprocessing included imputation, balancing of unequal classes and systematic feature selection. Seven ML models were trained and evaluated using performance metrics such as accuracy, recall and F1-score. Feature importance was interpreted using SHapley Additive exPlanations (SHAP)-based analysis.
resultsAmong the seven models evaluated, LightGBM demonstrated the best overall performance, achieving the highest accuracy (80%), sensitivity (91%), and area under the receiver operating characteristic curve (AUROC = 0.78). SHAP analysis identified place of delivery, antenatal care attendance, maternal tetanus vaccination, household wealth and maternal education as top predictors. DISCUSSION: Our findings suggest that machine learning, particularly LightGBM and XGBoost, is moderately effective in predicting the risk of zero-dose vaccination among children. This approach facilitates the easy identification of children most at risk of missing life-saving vaccinations.
conclusionThe LightGBM model predict children at zero-dose risk, enabling early identification and supporting intervention strategies. Future studies will scale these models using larger, routine datasets for practical implementation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.